Jump to content

Hindustan Antibiotics

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Yobot (talk | contribs) at 10:30, 21 October 2016 (→‎External links: CHECKWIKI error #22 (clean double space in category) / other fixes using AWB (12095)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Hindustan Antibiotics Limited
Company typePublic (PSE)
IndustryPharmaceuticals
Founded10 March 1954, Pimpri
HeadquartersPimpri, Maharashtra, India
Key people
Mrs.Neerja Saraf (Managing Director)
ProductsAntibiotics like Penicillin
Streptomycin
Gentamicin
Amoxycillin
RevenueUSD 12 million (FY)
Number of employees
1,500
Websitewww.hindantibiotics.gov.in

Hindustan Antibiotics Limited (HAL), based in Pimpri, India, is the first public sector drug manufacturing companies set up by the Government of India. It was the first company in India to launch a recombinant DNA product, rHU-Erythropoietin (Hemax) in 1993. The company introduced new products like Halpen, Haltax, Hexpan in 2008. Sati-HIV drugs will be produced from September 2009.[1]

History

HAL was set up in cooperation with the WHO and UNICEF with the social objective of providing affordable drugs throughout India. It was inaugurated by India's first Prime Minister Jawaharlal Nehru on 10 March 1954. Production began in 1955. It was based on Mahatma Gandhi's vision that the poor in India should get medicines at affordable rates.

After reporting an operating loss in 1997 the company was reported to the Bureau of Industrial and Financial Restructuring (BIFR). On 17 January 2009 the company was taken off the books of the BIFR after reporting a record turnover of 120 crore (US$24 million).

Operations

Although the company's primary objective was to develop drugs for the health-care industry, the company has now diversified into the agricultural and veterinary areas as well. The manufacturing plant located in Pimpri has facilities to produce bulk drugs (capacity 60 MMU annually) as well as formulations in various dosage forms - injectables (132 million vials), capsules (250 million), tablets (120 million), large volume parentrals[clarification needed] (12 million bottles annually), liquid orals, etc.

In-house developed products

Health care

  • Hamycin (own research product)
  • Ampicillin Sodium
  • Benzyl Penicillin Potassium
  • Benzyl Penicillin Sodium
  • Benzathine Penicillin (Longacillin)
  • Cefuroxime Sodium
  • Amoxycillin Trihydrate (Delamin)
  • Cefotaxime Sodium (Haltax)
  • Ceftriaxone Sodium (Haxone)
  • Meropenem (Halpen)

Agricultural and veterinary

  • Aureofungin (anti-fungal used in preservation of the fruits and vegetables)
  • Humaur (bio-organic foliar spray)
  • Streptocycline (antibacterial for effective control of diseases in plants)
  • Azotomeal
  • Phosphomeal

References

  1. ^ [1] Hindustan Antibiotics now out of ICU: Jan 18, 2009

External links